Author details

Full Name

Zhou Zhu

Affiliation

ORCID

Career Start Year

2002

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
35864202	PARP1-SNAI2 transcription axis drives resistance to PARP inhibitor, Talazoparib.	Sci Rep	2022
35974168	Comparative biomarker analysis of PALOMA-2/3 trials for palbociclib.	NPJ Precis Oncol	2022
34520734	Expanding control of the tumor cell cycle with a CDK2/4/6 inhibitor.	Cancer Cell	2021
33545944	Effectiveness and safety of different doses of tenecteplase in the treatment of acute ischemic stroke: A protocol for systematic review and meta-analysis.	Medicine (United States)	2021
31527167	Biomarker Analyses of Response to Cyclin-Dependent Kinase 4/6 Inhibition and Endocrine Therapy in Women with Treatment-NaÃ¯ve Metastatic Breast Cancer.	Clin Cancer Res	2020
30807234	Cyclin E1 Expression and Palbociclib Efficacy in Previously Treated Hormone Receptor-Positive Metastatic Breast Cancer.	J Clin Oncol	2019
29769744	NADPH ameliorates MPTP-induced dopaminergic neurodegeneration through inhibiting p38MAPK activation.	Acta Pharmacologica Sinica	2019
30700828	Combining CDK4/6 inhibition with taxanes enhances anti-tumor efficacy by sustained impairment of pRB-E2F pathways in squamous cell lung cancer.	Oncogene	2019
27488855	Atorvastatin Attenuates Ischemia/Reperfusion-Induced Hippocampal Neurons Injury Via Akt-nNOS-JNK Signaling Pathway.	Cellular and Molecular Neurobiology	2017
28329063	Lysosomal Proteolysis Is Associated With Exercise-Induced Improvement of Mitochondrial Quality Control in Aged Hippocampus.		2017
28967008	The N-allyl substituted effect on wormlike micelles and salt tolerance of a C-tailed cationic surfactant.	Soft Matter	2017
28965760	Chemical Proteomics Identifies Druggable Vulnerabilities in a Genetically Defined Cancer.	Cell	2017
27296290	Outlier analysis of functional genomic profiles enriches for oncology targets and enables precision medicine.	BMC Genomics	2016
26398286	Mitotic Checkpoint Kinase Mps1 Has a Role in Normal Physiology which Impacts Clinical Utility.	PLoS ONE	2015
25592564	Cell Index Database (CELLX): a web tool for cancer precision medicine.	Pac Symp Biocomput	2015
24928852	Chemogenetic evaluation of the mitotic kinesin CENP-E reveals a critical role in triple-negative breast cancer.	Molecular Cancer Therapeutics	2014
23505090	Genomic landscape of copy number aberrations enables the identification of oncogenic drivers in hepatocellular carcinoma.	Hepatology	2013
23820871	Combined gemcitabine and CHK1 inhibitor treatment induces apoptosis resistance in cancer stem cell-like cells enriched with tumor spheroids from a non-small cell lung cancer cell line.	Front Med	2013
23180468	Prevalence and predictive factors for poor sleep quality among migraineurs in a tertiary hospital headache clinic.	Acta Neurologica Belgica	2013
22849360	Dose-dependent effects of small-molecule antagonists on the genomic landscape of androgen receptor binding.	BMC Genomics	2012
20644729	Genome-wide mapping indicates that p73 and p63 co-occupy target sites and have similar dna-binding profiles in vivo.	PLoS One	2010
17571346	Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project.	Nature	2007
17122775	p63 protects the female germ line during meiotic arrest.	Nature	2006
17188034	Relationships between p63 binding, DNA sequence, transcription activity, and biological function in human cells.	Mol Cell	2006
15637633	Assessing computational tools for the discovery of transcription factor binding sites.	Nat Biotechnol	2005
15930495	Discovering functional transcription-factor combinations in the human cell cycle.	Genome Res	2005
12054769	Computational identification of transcription factor binding sites via a transcription-factor-centric clustering (TFCC) algorithm.	J Mol Biol	2002